EVMN Evommune, Inc.
NYSE · SEC CIK 2044725 · EDGAR
- Bought, last 12 months
- $70.16M 6 purchases by 6 insiders
- Sold, last 12 months
- $2.28M 8 sales by 6 insiders
- Filings on record
- 49 since 2025-11-07, latest 2026-07-10 19:59
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Verduyn-van Weegen Felice Isabel | Dir, 10% | $25.00M | — |
| LSP 7 Cooperative UA | Dir, 10% | $25.00M | — |
| RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $20.00M | — |
| Pena Luis C. | Pres, CEO, Dir | — | $550.7K |
| Drew Janice Suzann | EVP, Ops | — | $452.6K |
| Carver Kyle | CFO | $13.3K | $415.1K |
| Patel Jeegar Pravinkumar | CSO | — | $412.9K |
| Moss Gregory S. | Chief Business, Legal Off | — | $324.7K |
| KIRSCH ARTHUR S | Dir | $133.0K | — |
| Cohen David E | Dir | — | $123.1K |
Transactions 40
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 19:59 | 2026-07-08 | EVMN | Carver Kyle | CFO | P - Purchase | $13.26 | +1,000 | 60.3K | +2% | +$13.3K | |
| I | 2026-07-08 20:00 | 2026-07-07 | EVMN | KIRSCH ARTHUR S | Dir | P - Purchase | $13.30 | +10.0K | 10.0K | New | +$133.0K |
| DMT | 2026-06-24 20:00 | 2026-06-22 | EVMN | Drew Janice Suzann | Chief of Dev. Ops | M - OptEx | $3.15 | +20.0K | 87.8K | +30% | +$63.1K |
| DT | 2026-06-24 20:00 | 2026-06-22 | EVMN | Drew Janice Suzann | Chief of Dev. Ops | S - Sale+OE | $22.63 | -20.0K | 67.8K | -23% | -$452.6K |
| DT | 2026-06-24 20:00 | 2026-06-22 | EVMN | Patel Jeegar Pravinkumar | CSO | M - OptEx | $3.84 | +1,488 | 47.9K | +3% | +$5,714 |
| DT | 2026-06-24 20:00 | 2026-06-22 | EVMN | Patel Jeegar Pravinkumar | CSO | S - Sale+OE | $22.50 | -1,488 | 46.4K | -3% | -$33.5K |
| T | 2026-06-24 19:59 | 2026-06-22 | EVMN | Pena Luis C. | Pres, CEO, Dir | S - Sale | $22.71 | -7,438 | 630.5K | -1% | -$168.9K |
| DMT | 2026-06-03 20:03 | 2026-06-02 | EVMN | Cohen David E | Dir | S - Sale | $20.33 | -6,056 | 17.6K | -26% | -$123.1K |
| DT | 2026-06-03 20:02 | 2026-06-01 | EVMN | Patel Jeegar Pravinkumar | CSO | M - OptEx | $3.84 | +13.5K | 63.1K | +27% | +$51.9K |
| DT | 2026-06-03 20:02 | 2026-06-01 | EVMN | Patel Jeegar Pravinkumar | CSO | S - Sale+OE | $22.74 | -16.7K | 46.4K | -26% | -$379.5K |
| T | 2026-06-03 20:02 | 2026-06-01 | EVMN | Pena Luis C. | Pres, CEO, Dir | S - Sale | $22.74 | -16.8K | 637.9K | -3% | -$381.7K |
| DT | 2026-06-01 20:00 | 2026-05-28 | EVMN | Moss Gregory S. | Chief Business, Legal Off | M - OptEx | $1.71 | +14.2K | 75.1K | +23% | +$24.3K |
| DT | 2026-06-01 20:00 | 2026-05-28 | EVMN | Moss Gregory S. | Chief Business, Legal Off | S - Sale+OE | $22.83 | -14.2K | 60.8K | -19% | -$324.7K |
| DT | 2026-06-01 19:59 | 2026-05-28 | EVMN | Carver Kyle | CFO | M - OptEx | $2.99 | +15.0K | 77.5K | +24% | +$44.9K |
| DT | 2026-06-01 19:59 | 2026-05-28 | EVMN | Carver Kyle | CFO | S - Sale+OE | $22.84 | -18.2K | 59.3K | -23% | -$415.1K |
| I | 2026-02-19 | 2026-02-17 | EVMN | LSP 7 Cooperative UA | Dir, 10% | A - Grant | $27.88 | +358.7K | 5.29M | +7% | +$10.00M |
| I | 2026-02-18 | 2026-02-17 | EVMN | Verduyn-van Weegen Felice Isabel | Dir, 10% | A - Grant | $27.88 | +358.7K | 5.29M | +7% | +$10.00M |
| I | 2026-02-17 | 2026-02-17 | EVMN | RA Capital Healthcare Fund LP | Dir | A - Grant | $27.88 | +35.9K | 2.71M | +1% | +$1000.0K |
| I | 2025-12-22 | 2025-12-19 | EVMN | Hopfner Robert Lorne | Dir, 10% | P - Purchase | $17.35 | +1,000 | 4,026 | +33% | +$17.4K |
| 2025-12-11 | 2025-12-09 | EVMN | Carver Kyle | CFO | F - Tax | $17.84 | -13.3K | 62.5K | -18% | -$237.1K | |
| 2025-12-11 | 2025-12-09 | EVMN | Pena Luis C. | Pres, CEO, Dir | F - Tax | $17.84 | -28.1K | 654.7K | -4% | -$502.0K | |
| 2025-12-11 | 2025-12-09 | EVMN | Bauer Eugene | Chief Medical Off, Dir | F - Tax | $17.84 | -1,478 | 270.8K | -0.5% | -$26.4K | |
| 2025-12-11 | 2025-12-09 | EVMN | Patel Jeegar Pravinkumar | CSO | F - Tax | $17.84 | -7,513 | 49.6K | -13% | -$134.0K | |
| 2025-12-11 | 2025-12-09 | EVMN | Moss Gregory S. | Chief Business, Legal Off | F - Tax | $17.84 | -13.6K | 60.8K | -18% | -$243.1K | |
| 2025-12-11 | 2025-12-09 | EVMN | Drew Janice Suzann | EVP, Ops | F - Tax | $17.84 | -5,074 | 67.8K | -7% | -$90.5K | |
| DI | 2025-11-12 | 2025-11-07 | EVMN | Moss Gregory S. | Chief Business, Legal Off | C - Cnv Deriv | — | +3,175 | 3,175 | New | — |
| D | 2025-11-12 | 2025-11-07 | EVMN | Drew Janice Suzann | EVP, Ops | C - Cnv Deriv | — | +1,587 | 72.9K | +2% | — |
| DMI | 2025-11-12 | 2025-11-07 | EVMN | Pivotal bioVenture Partners Fund I G.P., L.P. | Dir, 10% | C - Cnv Deriv | — | +3.37M | 294.5K | New | — |
| D | 2025-11-12 | 2025-11-07 | EVMN | Patel Jeegar Pravinkumar | CSO | C - Cnv Deriv | — | +3,175 | 57.1K | +6% | — |
| DI | 2025-11-12 | 2025-11-07 | EVMN | Verduyn-van Weegen Felice Isabel | Dir, 10% | C - Cnv Deriv | — | +3.37M | 3.37M | New | — |
| DI | 2025-11-12 | 2025-11-07 | EVMN | Verduyn-van Weegen Felice Isabel | Dir, 10% | P - Purchase | $16.00 | +1.56M | 4.93M | +46% | +$25.00M |
| D | 2025-11-12 | 2025-11-07 | EVMN | Cohen David E | Dir | C - Cnv Deriv | — | +6,056 | 23.7K | +34% | — |
| DMI | 2025-11-12 | 2025-11-07 | EVMN | Hopfner Robert Lorne | Dir, 10% | C - Cnv Deriv | — | +3.37M | 1.63M | New | — |
| DMI | 2025-11-12 | 2025-11-07 | EVMN | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | C - Cnv Deriv | — | +2.21M | 691.4K | New | — |
| DMI | 2025-11-12 | 2025-11-07 | EVMN | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $16.00 | +1.25M | 784.3K | New | +$20.00M |
| D | 2025-11-12 | 2025-11-07 | EVMN | Carver Kyle | CFO | C - Cnv Deriv | — | +3,175 | 75.8K | +4% | — |
| D | 2025-11-12 | 2025-11-07 | EVMN | Bauer Eugene | Chief Medical Off, Dir | C - Cnv Deriv | — | +25.8K | 272.3K | +10% | — |
| D | 2025-11-12 | 2025-11-07 | EVMN | LSP 7 Cooperative UA | 10% | C - Cnv Deriv | — | +3.37M | 3.37M | New | — |
| D | 2025-11-12 | 2025-11-07 | EVMN | LSP 7 Cooperative UA | 10% | P - Purchase | $16.00 | +1.56M | 4.93M | +46% | +$25.00M |
| D | 2025-11-12 | 2025-11-07 | EVMN | Pena Luis C. | Pres, CEO, Dir | C - Cnv Deriv | — | +24.2K | 682.8K | +4% | — |
Purchase Sale Sale after option exercise All abbreviations